These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3803393

  • 1. Biologically potent analogues of salmon calcitonin which do not contain an N-terminal disulfide-bridged ring structure.
    Orlowski RC, Epand RM, Stafford AR.
    Eur J Biochem; 1987 Jan 15; 162(2):399-402. PubMed ID: 3803393
    [Abstract] [Full Text] [Related]

  • 2. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
    Epand RM, Epand RF, Stafford AR, Orlowski RC.
    J Med Chem; 1988 Aug 15; 31(8):1595-8. PubMed ID: 3397998
    [Abstract] [Full Text] [Related]

  • 3. des-Ser2 salmon calcitonin: a biologically potent synthetic analog.
    Schwartz KE, Orlowski RC, Marcus R.
    Endocrinology; 1981 Mar 15; 108(3):831-5. PubMed ID: 6257497
    [Abstract] [Full Text] [Related]

  • 4. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
    Yates AJ, Gutierrez GE, Garrett IR, Mencel JJ, Nuss GW, Schreiber AB, Mundy GR.
    Endocrinology; 1990 Jun 15; 126(6):2845-9. PubMed ID: 2351097
    [Abstract] [Full Text] [Related]

  • 5. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S, Findlay DM, Brady CL, Martin TJ, Epand RM, Moore EE, Murayama E, Tamura T, Orlowski RC, Sexton PM.
    Mol Pharmacol; 1995 Apr 15; 47(4):798-809. PubMed ID: 7723741
    [Abstract] [Full Text] [Related]

  • 6. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
    Taylor JW, Jin QK, Sbacchi M, Wang L, Belfiore P, Garnier M, Kazantzis A, Kapurniotu A, Zaratin PF, Scheideler MA.
    J Med Chem; 2002 Feb 28; 45(5):1108-21. PubMed ID: 11855991
    [Abstract] [Full Text] [Related]

  • 7. Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues.
    Kapurniotu A, Taylor JW.
    J Med Chem; 1995 Mar 03; 38(5):836-47. PubMed ID: 7877149
    [Abstract] [Full Text] [Related]

  • 8. Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes.
    Twery MJ, Seitz PK, Nickols GA, Cooper CW, Gallagher JP, Orlowski RC.
    Eur J Pharmacol; 1988 Oct 18; 155(3):285-92. PubMed ID: 3266153
    [Abstract] [Full Text] [Related]

  • 9. Conformational requirements for activity of salmon calcitonin.
    Findlay DM, Michelangeli VP, Martin TJ, Orlowski RC, Seyler JK.
    Endocrinology; 1985 Sep 18; 117(3):801-5. PubMed ID: 4017965
    [Abstract] [Full Text] [Related]

  • 10. Renal receptors for calcitonin: coordinate occurrence with calcitonin-activated adenylate cyclase.
    Marx SJ, Aurbach GD.
    Endocrinology; 1975 Aug 18; 97(2):448-53. PubMed ID: 169126
    [Abstract] [Full Text] [Related]

  • 11. Calcitonin-sensitive adenylate cyclase in rat renal tubular membranes.
    Loreau N, Lepreux C, Ardaillou R.
    Biochem J; 1975 Sep 18; 150(3):305-14. PubMed ID: 2153
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and characterization of a model peptide having potent calcitonin-like biological activity: implications for calcitonin structure/activity.
    Moe GR, Kaiser ET.
    Biochemistry; 1985 Apr 09; 24(8):1971-6. PubMed ID: 2990546
    [Abstract] [Full Text] [Related]

  • 13. Structure/function relationships of calcitonin analogues as agonists, antagonists, or inverse agonists in a constitutively activated receptor cell system.
    Pozvek G, Hilton JM, Quiza M, Houssami S, Sexton PM.
    Mol Pharmacol; 1997 Apr 09; 51(4):658-65. PubMed ID: 9106632
    [Abstract] [Full Text] [Related]

  • 14. Stable human calcitonin analogues with high potency on bone together with reduced anorectic and renal actions.
    Uda K, Kobayashi Y, Hisada T, Orlowski RC, Bastian JW, Arnaud CD, Wakabayashi K.
    Biol Pharm Bull; 1999 Mar 09; 22(3):244-52. PubMed ID: 10220278
    [Abstract] [Full Text] [Related]

  • 15. Calcitonin gene related peptide stimulates adenylate cyclase activity in rat striated muscle.
    Kobayashi H, Hashimoto K, Uchida S, Sakuma J, Takami K, Tohyama M, Izumi F, Yoshida H.
    Experientia; 1987 Mar 15; 43(3):314-6. PubMed ID: 3493916
    [Abstract] [Full Text] [Related]

  • 16. Calcitonin gene-related peptide stimulates adenylate cyclase activation via a guanine nucleotide-dependent process in rat liver plasma membranes.
    Yamaguchi A, Chiba T, Yamatani T, Inui T, Morishita T, Nakamura A, Kadowaki S, Fukase M, Fujita T.
    Endocrinology; 1988 Nov 15; 123(5):2591-6. PubMed ID: 3049052
    [Abstract] [Full Text] [Related]

  • 17. Conformational flexibility and biological activity of salmon calcitonin.
    Epand RM, Epand RF, Orlowski RC, Seyler JK, Colescott RL.
    Biochemistry; 1986 Apr 22; 25(8):1964-8. PubMed ID: 3707923
    [Abstract] [Full Text] [Related]

  • 18. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS, Nicholson GC, Moseley JM, Evans T, Martin TJ, Kemp BE.
    Endocrinology; 1988 Sep 22; 123(3):1483-8. PubMed ID: 2841096
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.